Cargando…
A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids
The broad research use of organoids from high-grade serous ovarian cancer (HGSC) has been hampered by low culture success rates and limited availability of fresh tumor material. Here, we describe a method for generation and long-term expansion of HGSC organoids with efficacy markedly improved over p...
Autores principales: | Senkowski, Wojciech, Gall-Mas, Laura, Falco, Matías Marín, Li, Yilin, Lavikka, Kari, Kriegbaum, Mette C., Oikkonen, Jaana, Bulanova, Daria, Pietras, Elin J., Voßgröne, Karolin, Chen, Yan-Jun, Erkan, Erdogan Pekcan, Dai, Jun, Lundgren, Anastasia, Grønning Høg, Mia Kristine, Larsen, Ida Marie, Lamminen, Tarja, Kaipio, Katja, Huvila, Jutta, Virtanen, Anni, Engelholm, Lars, Christiansen, Pernille, Santoni-Rugiu, Eric, Huhtinen, Kaisa, Carpén, Olli, Hynninen, Johanna, Hautaniemi, Sampsa, Vähärautio, Anna, Wennerberg, Krister |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281085/ https://www.ncbi.nlm.nih.gov/pubmed/37148882 http://dx.doi.org/10.1016/j.devcel.2023.04.012 |
Ejemplares similares
-
Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer
por: Zhang, Kaiyang, et al.
Publicado: (2022) -
PRISM: recovering cell-type-specific expression profiles from individual composite RNA-seq samples
por: Häkkinen, Antti, et al.
Publicado: (2021) -
Network-guided identification of cancer-selective combinatorial therapies in ovarian cancer
por: He, Liye, et al.
Publicado: (2021) -
A Subset of Secreted Proteins in Ascites Can Predict Platinum-Free Interval in Ovarian Cancer
por: Carroll, Molly J., et al.
Publicado: (2022) -
Quantification of cell death and proliferation of patient-derived ovarian cancer organoids through 3D imaging and image analysis
por: Skorda, Aikaterini, et al.
Publicado: (2023)